Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SK-PC-B70M in mild to moderate Alzheimer's disease
NCT00443417Phase 2Completed
- Sponsor
- SK Chemicals
- Start
- Apr 2007
- Primary completion
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SK-PC-B70M in Alzheimer's disease (AD), sponsored by SK Chemicals. Started Apr 2007; status: completed.
02
Drugs
SK-PC-B70M
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00443417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00443417.